Clinical Trials Browser

OTHER × Lung Diseases × Diarylheptanoids × Clear all

NCT03598309 2026-02-27

Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers

Phase 2 Active not recruiting

Lung Diseases, Lung Neoplasms